Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis: the CONF-UC Study
NCT06624579 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2024-10-03
Summary
This study employs a prospective, single-center, interventional design to investigate the prognostic value of confocal endomicroscopy in assessing treatment response in ulcerative colitis (UC) patients receiving small molecules .
Conditions
Interventions
- PROCEDURE
-
confocal endomicroscopy
The study incorporates confocal endomicroscopy as an additional diagnostic modality for assessing barrier dysfunction and treatment response in UC patients. Confocal endomicroscopy enables real-time visualization of mucosal changes at a cellular level during endoscopy, potentially enhancing the detection of treatment response and mucosal healing.
Sponsors & Collaborators
-
FEDERICA FURFARO
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2025-10-31
- Completion
- 2026-06-30
More Related Trials
-
Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis
NCT01434576 ·Status: WITHDRAWN ·Phase: PHASE1
-
Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study
NCT03772145 ·Status: TERMINATED
-
Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)
NCT02516384 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
NCT01852760 ·Status: COMPLETED
-
Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative Colitis
NCT05735665 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
NCT05786404 ·Status: RECRUITING ·Phase: PHASE1
-
Responsiveness of Endoscopic Evaluation in UC
NCT01960439 ·Status: COMPLETED
-
Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova
NCT01433471 ·Status: COMPLETED ·Phase: NA
-
Regulation of Mucosal Healing in Inflammatory Bowel Disease
NCT04504136 ·Status: RECRUITING ·Phase: NA
-
Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis
NCT04926103 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis
NCT02227342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
NCT06693310 ·Status: RECRUITING ·Phase: NA
-
Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis
NCT03863886 ·Status: UNKNOWN ·Phase: NA
-
Local and Systemic Immunoprofiling of Patients Diagnosed With Ulcerative Colitis
NCT05680883 ·Status: UNKNOWN
-
Comparative Outcomes of Ulcerative Colitis Patients With Mayo Endoscopic Score 1 and Histologic Activity Versus Mayo Endoscopic Score 2
NCT07188727 ·Status: COMPLETED
-
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
NCT03847467 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Endomicroscopy in Ulcerative Colitis
NCT00659867 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2
-
FMT in Ulcerative Colitis-Associated Pouchitis
NCT02049502 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis
NCT05180279 ·Status: COMPLETED ·Phase: NA
-
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
NCT01065571 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine
NCT06525974 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
NCT02438410 ·Status: COMPLETED
-
A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis
NCT03698812 ·Status: UNKNOWN
-
Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
NCT05907330 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2